Bracco is an international Group, active in the healthcare sector and a leader in diagnostic imaging. In the Research and Development area, the company invests approximately 10% of reference turnover in the imaging diagnostics and medical devices sectors and has a portfolio comprising over 2,000 patents. The Group’s main products are contrast agents, medical substances used to improve the diagnostic accuracy of biomedical imaging and the care of patients affected by diseases of varying type and severity. Bracco contrast media are sold in over 100 countries, both directly and indirectly through branches, joint ventures and licence and distribution agreements. Thanks to the quality and reliability of its products, the Group boasts leading positions in the most important geographical areas such as North America, China, Europe and Japan.
The Bracco diagnostic imaging product portfolio is completed by medical devices and advanced imaging agents injection systems (Acist and Bracco Injeneering).
Based in Eden Prairie, Minnesota, ACIST Medical Systems, part of the Bracco Group, was founded by an interventional cardiologist on a mission.Dr. Robert (Bob) F. Wilson, Professor of Medicine and Director of the Interventional Cardiology Program at the University of Minnesota, wanted to create a device that took into consideration the needs of both physicians and patients in the cath lab. This sparked the creation of ACIST CVi™, a device that simplifies contrast injection for all procedures. Since then, ACIST has become a knowledge catalyst, helping interventional cardiologists quickly visualize, assess and improve patient treatment.